NCT00832546View on ClinicalTrials.gov

A Safety Tolerance and Experimental Hyperalgesia Study of Oral NGX426 in Healthy Male Voluneteers

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
HealthyHyperalgesia
Interventions
DRUG

Placebo

DRUG

Oral NGX426 (Powder in solution)

Trial Locations (1)

92037

University of California, San Diego

Sponsors
All Listed Sponsors
lead

TorreyPines Therapeutics

INDUSTRY

NCT00832546 - A Safety Tolerance and Experimental Hyperalgesia Study of Oral NGX426 in Healthy Male Voluneteers | Biotech Hunter | Biotech Hunter